课题基金 / 基金详情

NCMRR-DC Core Molecular & Functional Outcome Measures in Rehabilitation Medicine

NCMRR-DC Core Molecular & Functional Outcome Measures in Rehabilitation Medicine
NCMRR-DC核心分子
批准号:
8115760
负责人:
ERIC P. HOFFMAN
金额:
$94.23万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-09-15 至 2015-05-31

项目摘要

项目成果

ERIC P. HOFFMAN的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):医疗康复是一个跨年龄段的研究和临床问题。早产儿需要多种类型的康复(身体,呼吸,职业),脑瘫和脊柱裂儿童有广泛的康复需求。患有脊髓、脑和肢体创伤的成年人都需要广泛的康复支持。研究以改善功能结果,并了解特定残疾的病理生理学是很重要的,无论是病人的生活质量,以及对医疗保健系统的负担。我们的NCMRR-DC核心的目标是在康复研究中提供分子和功能结果测量的技术服务和培训。在上一个授予期间,我们的NCMRR核心为32个机构的108名主要研究者提供了服务和培训,处理和分析了超过4,500个样本。教学和外联工作包括对外部调查人员进行超过3 500小时的现场培训,95次特邀讲座,在国家和国际会议上作29次演讲,并组织讲习班编写和传播功能成果措施的标准作业程序。在这项竞争性更新申请中,PI已将其分子结果服务和培训扩展到包括小鼠和人类功能结果。这些措施包括临床评价服务和培训,鼠功能测试设施,并促进辅助研究,在预先存在的人类队列强调功能的结果。这些新资源是在过去4年中建立的,已被国际康复研究界大量利用,现在被提议作为NCMRR-DC核心的一部分。 公共卫生相关性:研究以改善功能结果,并了解特定残疾的病理生理学是很重要的,无论是病人的生活质量,以及对医疗保健系统的负担。NCMRR-DC核心的目标是在康复研究中提供分子和功能结果测量的技术服务和培训。
英文摘要
DESCRIPTION (provided by applicant): Medical rehabilitation is a research and clinical concern across the age span. Premature infants require rehabilitation of multiple types (physical, respiratory, occupational), children with cerebral palsy and spina bifida have extensive rehabilitation needs. Adults with spinal cord, brain, and limb trauma all require extensive rehabilitation support. Research to improve functional outcomes, and understand the pathophysiology of specific disabilities is important, both for patient quality of life, as well as burden on the health care system. The goal of our NCMRR-DC Core is to provide technical services and training across both molecular and functional outcome measures in rehabilitation research. During the previous award period, our NCMRR Core provided services and training to 108 principal investigators in 32 institutions, with processing and analysis of >4,500 samples. Didactic and outreach efforts included >3,500 hrs of on-site training of external investigators, 95 invited lectures, 29 presentations at national and international conferences, and organization of workshops to write and disseminate standard operating procedures for functional outcome measures. In this competitive renewal application, the PIs have extended their molecular outcomes services and training to include murine and human functional outcomes. These include clinical evaluator services and training, a murine functional testing facility, and facilitation of ancillary studies in pre-existing human cohorts emphasizing functional outcomes. These new resources have been established over the last 4 years, have been heavily utilized by the international rehabilitation research community, and are now proposed as a part of the NCMRR-DC Core. PUBLIC HEALTH RELEVANCE: Research to improve functional outcomes, and understand the pathophysiology of specific disabilities is important, both for patient quality of life, as well as burden on the health care system. The goal of the NCMRR-DC Core is to provide technical services and training across both molecular and functional outcome measures in rehabilitation research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Clinical Trial Readiness for Monitoring Muscle Inflammation in Duchenne Muscular Dystrophy
  • 批准号:
    10725465
  • 项目类别:
  • 资助金额:
    $23.74万
  • 财政年份:
    2023
  • 负责人:
    ERIC P. HOFFMAN
  • 依托单位:
Commercialization Readiness Pilot (CRP) to maximize vamorolone international labeling and sales
  • 批准号:
    10200153
  • 项目类别:
  • 资助金额:
    $167.24万
  • 财政年份:
    2016
  • 负责人:
    ERIC P. HOFFMAN
  • 依托单位:
K12 Career Development Program: Omics of Pediatric Lung Diseases in DC
  • 批准号:
    8857246
  • 项目类别:
  • 资助金额:
    $26.89万
  • 财政年份:
    2013
  • 负责人:
    ERIC P. HOFFMAN
  • 依托单位:
K12 Career Development Program: Omics of Pediatric Lung Diseases in DC
  • 批准号:
    8722615
  • 项目类别:
  • 资助金额:
    $26.95万
  • 财政年份:
    2013
  • 负责人:
    ERIC P. HOFFMAN
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: